Capturing Interpatient Variability with SimPops
Keywords: AEC, CARDIOsym, clinical, clinical data, DILIsym, disease progression, DLCO, fibrosis, FVC, Genetic algorithms, honeycombing, HRCT, ILDsym, immune, IPFsym, KIDNEYsym, lung collagen, mediator, MITOsym, model, NAFLDsym, pathophysiology, pirfenidone, proteoglycan, quantitative systems pharmacology (QSP), Quantitative Systems Toxicology (QST), RENAsym, SimPops, treatmentSoftware: Capturing Interpatient Variability with SimPops, DILIsym®, ILDsym™, IPFsym®, Capturing Interpatient Variability with SimPops, MITOsym®, NAFLDsym®, RENAsym®Conference: ASCPTDivision: DILIsym Services
By Scott Q. Siler
Presented at American Society for Clinical Pharmacology & Therapeutics (ASCPT) Network & Community Experience, January 10-14, 2022